The UK Dementia Research Institute and Imperial College London are conducting a trial that uses advanced sensor technology to monitor the daily lives of dementia patients in their homes. The study, funded by medical research charity LifeArc, involves more than 250 participating families who have agreed to allow continuous monitoring of their movements and habits through various connected devices.
One couple participating in the program includes Jyoti, who received an Alzheimer’s diagnosis in 2021 after symptoms became apparent during her professional performances, and her husband Bharat. Their west London home is equipped with multiple sensors that track door openings, detect falls, monitor kitchen activity, and gather data on sleep patterns and vital signs. The couple also wear smart socks and a special watch equipped with sensors that track body temperature and gait changes. A smart mattress monitors sleep disturbances, heart rate, and breathing patterns to identify early signs of infection.
The monitoring system transmits data to a team of doctors, nurses, and clinical specialists who analyze the information to understand how patients manage daily routines and identify early warning signs of health changes. The technology is designed to help patients maintain independence longer and prevent unnecessary hospital admissions. Annual costs for the program are estimated at approximately £2,000 per household, primarily covering monitoring services and staff time for data analysis.
According to Sarah Daniels, health and social care lead at the UK Dementia Research Institute, the cost compares favorably to brief stays in care facilities. Early detection capabilities allow healthcare professionals to intervene before potential complications from infections or other health challenges become critical. All devices protect privacy by excluding audio and video recording capabilities, though data access raises privacy considerations for some participants.
With dementia cases in the UK projected to increase by 40% by 2040, health officials are exploring wider implementation of the technology across the NHS. Dr Jeremy Isaacs, national clinical director for dementia and older people’s mental health at NHS England, indicated the service would closely monitor the trial results as part of broader efforts to support independent living among older adults.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI